Former Aspreva executives’ new company nets $56 million in private placement

Aurinia Pharmaceuticals Inc. (TSX-V:AUP), a Victoria-based biotech whose team includes the founders of British Columbia’s most successful biopharmaceutical companies – Aspreva Pharmaceuticals – has secured $56 million in private ...